UNSPSC 85282202: Diagnosis of systemic atrophy primarily affecting central nervous system in myxoedema

This classification denotes the group of activities that yields a diagnosis of Systemic atrophy primarily affecting central nervous system in myxoedema. Systemic atrophy primarily affecting central nervous system in myxoedema is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code G13. 2

UNSPSC 85282202, Diagnosis of systemic atrophy primarily affecting central nervous system in myxoedema, is a Commodity code with minimal alignment to recent state and local procurement activity. The code's nominal scope — a specific neurological diagnostic classification — does not match the work actually being solicited under it in public records.

Recent opportunities posted under this code include a diagnostic imaging Picture Archiving and Communication System (PACS) procurement from San Mateo Medical Center, a special education contracted services vehicle from Birdville Independent School District in Texas, and a temporary health professional staffing qualification pool from Santa Clara County Health System in California. None of these solicitations address the neurological diagnosis named in the code. The mismatch suggests either a coding error in the source data or use of this code as a catch-all placeholder for health services procurement without true category relevance. State and local governments do not appear to be using this code to procure services or diagnostic work related to myxoedema or central nervous system atrophy. Pursuit of opportunities tagged with this code warrants verification of the actual scope against stated business capability before investing RFP response effort.